Fulcrum Therapeutics Inc (NASDAQ:FULC)
| 4.91 Delayed Data As of Jul 01 |  +0.01 / +0.20%Today’s Change | 3.21 Today|||52-Week Range 33.10 | -72.24% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2017 | 2018 | -- | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | -- | -- | -- |
| Depreciation And Amortization | 715.0K | 1.3M | -- | -- | ||
| Operating Expenses | Gross Income | -715.0K | -1.3M | -- | -- | |
| General Expenses | 22.3M | 32.2M | -- | -- | ||
| Research And Development | 18.5M | 25.2M | -- | -- | ||
| Total Operating Expenses | 23.0M | 33.5M | -- | -- | ||
| Non-Operating Expenses | Operating Income | -23.0M | -33.5M | -- | -- | |
| Other Expenses | 28.0K | 392.0K | -- | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -23.0M | -32.6M | -- | -- | |
| Preferred Dividend | -2.4M | -6.6M | -- | -- | ||
| Net Income | -23.0M | -32.6M | -- | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 23.3M | 23.3M | -- | -- | |
| Shares To Calculate EPS Diluted | 23.3M | 23.3M | -- | -- | ||
| Earnings Per Share | EPS | -$5.09 | -$4.45 | -- | -- | |
| EPS Diluted | -$1.09 | -$1.68 | -- | -- | ||
